Multicenter Randomized Phase II Study Evaluating Tolerance and Efficacy of Capecitabine 5/7 Days With Weekly Paclitaxel Versus the Recommended Treatment Plan of Weekly Paclitaxel-capecitabine, in Patients With Metastatic Breast Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2012
At a glance
- Drugs Capecitabine (Primary) ; Paclitaxel
- Indications Advanced breast cancer
- Focus Adverse reactions
- 01 Jan 2012 Results published in Breast Cancer Research and Treatment.
- 24 Feb 2011 Actual end date (Oct 2010) added as reported by ClinicalTrials.gov.
- 24 Feb 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.